TABLE 2

Statistical Correlation Between Clinical Markers of Symptomatic HD Subjects and Fractional Brain Volumes

Age-adjusted fGMfWMAge-adjusted fCSF
Clinical markernSrPSrPSrP
Duration of disease (y)47NS−0.54<0.00010.470.0013
Stage (total functional capacity score)470.310.0350.460.0014−0.52<0.0001
Loss of total functional capacity units per year36*−0.330.048NS0.37<0.026
  • * Patients beyond 5 y from onset of HD.

  • Sr = Spearman rank correlation; NS = not significant.